02555625985N Engl J MedN. Engl. J. Med.The New England journal of medicine0028-47931533-440623215575411532410.1056/NEJMc1202292NIHMS601248ArticleLow neutrophilss in African mothers and newborns and HIV transmission riskKourtisAthena P.MD, PhDHudgensMichael G.PhD*KayiraDumbaniMBBS**the BAN Study Team***Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, University of North Carolina (UNC) at Chapel HillDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, UNC Project-MalawiCorresponding Author: Athena P. Kourtis, apk3cdc.gov1662014612201230720143672322602262

TO THE EDITOR: Ethnic neutropenia is highly prevalent in individuals of African descent.1,2 It was also observed in the Breastfeeding, Antiretrovirals, and Nutrition (BAN) study of 2,369 HIV-infected mothers and their newborns in Malawi.1, 3 Low neutrophil counts in Africans are thought to represent a variation with undefined and largely unexplored consequences. A recent study suggested that low pre-infection neutrophil counts were associated with increased risk of sexually transmitted HIV infection in South African black women.4 Notably, in genome-wide association analyses, an African-specific polymorphism in the promoter of Duffy antigen receptor for chemokines (the Duffy-null trait that imparts resistance to malaria) was significantly predictive of (and thought to be causal for5) low neutrophil counts.4 We examined the association of neutrophil counts in mothers and newborns with risk of infant perinatal HIV infection in the BAN cohort. Timing of infant perinatal HIV infection was determined by a confirmed positive HIV PCR test result in the first 48 hours of life (in utero) or by 2 weeks of age (intrapartum). The BAN protocol was approved by the Malawi National Health Sciences Research Committee and the institutional review boards of the University of North Carolina and the Centers for Disease Control and Prevention.

Maternal and infant neutrophil counts of perinatally HIV-infected infants (N=119) were lower than those of perinatally uninfected infants (N=2250) (Table 1). Almost all (N=114) infants acquired their infection in utero, since mothers in BAN started antiretroviral prophylaxis at onset of labor. Infant WBC and neutrophil counts were collected on the day of or the day after birth in 90.1% of cases, with no difference in timing between HIV-infected and uninfected infants. Higher neutrophil counts in the mother (risk ratio [RR], 0.93; p=0.02) and in the newborn (RR, 0.89; p<0.001) were associated with lower risk of perinatal HIV infection (see Web Supplement Figure). The association of infant neutrophil counts with perinatal HIV infection persisted after adjustment (adjusted RR, 0.88; p=0.03) for maternal CD4+ levels, cotrimoxazole use during pregnancy, infant gender, birth weight, and maternal log10 viral load. Each 1,000-cell/µl increment in the infant’s neutrophil count was associated with 11% reduction in the risk of perinatal HIV infection. Maternal neutrophil count was associated with perinatal HIV infection after adjustment for cotrimoxazole use, CD4+ count, infant gender and birth weight (p=0.045).

Association of low neutrophil counts in the mother and the newborn with increased susceptibility to perinatal HIV infection is a novel observation. Neutropenia in the newborn is not typically a feature of in utero HIV infection, and a concomitant decrease in the lymphocyte/monocyte fraction was not seen (Table 1). Pregnant women with low neutrophil counts may need more targeted and earlier approaches to prevent intrauterine transmission of HIV to the infant. New paths to prevention may result from genetic studies to investigate the relationship of Duffy-null trait or other genetic polymorphisms that underlie low ethnic neutrophil counts in individuals of African ancestry and increased susceptibility to perinatal HIV infection.

Supplementary Material

The authors have no financial conflicts to disclose.

Supported by grants from the Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention (SIP 13-01 U48-CCU409660-09 and SIP 26-04 U48-DP000059-01), the National Institute of Allergy and Infectious Diseases, the University of North Carolina Center for AIDS Research (P30-AI50410), the NIH Fogarty AIDS International Training and Research Program (DHHS/NIH/FIC 2-D43 Tw01039-06), Abbott Laboratories, GlaxoSmithKline, Boehringer Ingelheim, Roche Pharmaceuticals, Bristol-Myers-Squibb, the Elizabeth Glaser Pediatric AIDS Foundation, the United Nations Children’s Fund, the World Food Program, the Malawi Ministry of Health and Population, Johnson & Johnson, and the U.S. Agency for International Development.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Appendix

BAN Study Team at University of North Caroline Chapel Hill, Centers for Disease Control and Prevention, Atlanta, and UNC Project team in Lilongwe, including: Linda Adair, Yusuf Ahmed, Mounir Al-Khaled, Sandra Albrecht, Shrikant Bangdiwala, Ronald Bayer, Margaret Bentley, Brian Bramson, Emily Bobrow, Nicola Boyle, Sal Butera, Charles Chasela, Charity Chavula, Joseph Chimerang’ambe, Maggie Chigwenembe, Maria Chikasema, Norah Chikhungu, David Chilongozi, Grace Chiudzu, Lenesi Chome, Anne Cole, Amanda Corbett, Amy Corneli, Anna Dow, An Duerr, Henry Eliya, Sascha Ellington, Joseph Eron, Sherry Farr, Yvonne Owens Ferguson, Susan Fiscus, Valerie Flax, Ali Fokar, Shannon Galvin, Laura Guay, Chad Heilig, Irving Hoffman, Elizabeth Hooten, Mina Hosseinipour, Michael Hudgens, Stacy Hurst, Lisa Hyde, Denise Jamieson, George Joaki (deceased), David Jones, Elizabeth Jordan-Bell, Zebrone Kacheche, Esmie Kamanga, Gift Kamanga, Coxcilly Kampani, Portia Kamthunzi, Deborah Kamwendo, Cecilia Kanyama, Angela Kashuba, Damson Kathyola, Dumbani Kayira, Peter Kazembe, Caroline C. King, Rodney Knight, Athena P. Kourtis, Robert Krysiak, Jacob Kumwenda, Hana Lee, Edde Loeliger, Dustin Long, Misheck Luhanga, Victor Madhlopa, Maganito Majawa, Alice Maida, Cheryl Marcus, Francis Martinson, Navdeep Thoofer, Chrissie Matiki (deceased), Douglas Mayers, Isabel Mayuni, Marita McDonough, Joyce Meme, Ceppie Merry, Khama Mita, Chimwemwe Mkomawanthu, Gertrude Mndala, Ibrahim Mndala, Agnes Moses, Albans Msika, Wezi Msungama, Beatrice Mtimuni, Jane Muita, Noel Mumba, Bonface Musis, Charles Mwansambo, Gerald Mwapasa, Jacqueline Nkhoma, Megan Parker, Richard Pendame, Ellen Piwoz, Byron Raines, Zane Ramdas, John Rublein, Mairin Ryan, Ian Sanne, Christopher Sellers, Diane Shugars, Dorothy Sichali, Wendy Snowden, Alice Soko, Allison Spensley, Jean-Marc Steens, Gerald Tegha, Martin Tembo, Roshan Thomas, Hsiao-Chuan Tien, Beth Tohill, Charles van der Horst, Esther Waalberg, Elizabeth Widen, Jeffrey Wiener, Cathy Wilfert, Patricia Wiyo, Innocent Zgambo, Chifundo Zimba.

ReferencesKourtisAPBramsonBvan der HorstCLow absolute neutrophil counts in African infantsJ Int Assoc Physicians AIDS Care200547376WellsJShettyAKStranixLRange of normal neutrophil counts in healthy Zimbambwean infants: implications for monitoring antiretroviral drug toxicityJ Acquir Immune Defic Syndr20064246046316810112ChaselaCSHudgensMGJamiesonDJMaternal or infant antiretroviral drugs to reduce HIV transmissionN Engl J Med20103622271228120554982RamsuranVKulkarniHHeWDuffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenClin Infect Dis2011521248125621507922ReichDNallsMAKaoWHReduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines genePLoS Genet20095e100036019180233

Neutrophil Counts and Select Other Characteristics of Perinatally HIV-Infected vs. Uninfected Infants in the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study§

Perinatally HIV-Infected(N=119)Not Infected Perinatally(N=2250)P-Value
Maternal characteristics
CD4+ count (cells/µL)396 (304–518)439 (330–582)0.02
White Blood Cell (WBC) count (103/µL)9.4 (7.3 –11.5)10.1 (8.1 –12.8)0.02
Neutrophil count (103/µL)6.1 (4.5 –8.0)7.0 (5.2 –9.4)0.02
(WBC less Neutrophil) count (mostly lymphocytes/monocytes) (103/µL)2.9 (2.4 –3.6)3.1 (2.5 –3.8)0.39
Log10 viral load*4.6 (4.0–5.0)2.9 (2.3–3.7)<0.001
Infant characteristics
Gender (male) (%)45.350.40.28
Birth weight (kg)2.9 (2.6–3.2)3.0 (2.7–3.3)0.002
WBC count (103/µL)13.6 (11.0–17.4)15.0 (12.1–17.8)0.36
Neutrophil count (103/µL)6.4 (4.8–8.7)8.0 (6.1–10.0)<0.001
(WBC less Neutrophil) count (mostly lymphocytes/monocytes) (103/µL)6.9 (5.6 –8.7)6.7 (5.5 –8.2)0.005

Data were available for all n=2369 mother-infant pairs with the following exceptions: one mother had an infeasible pair of WBC and neutrophil counts which were set to missing; birth weight was missing for two infants; WBC counts were missing for 60 infants (4 HIV-infected); neutrophil counts were missing for 58 infants (5 HIV-infected); and the WBC less neutrophil variable was missing for 61 infants (5 infected). Maternal viral loads were obtained using case-control sampling, with measurements from all infected infants with available specimens (97 of the 119 total cases) and a sample of controls with available specimens (122 of the 2250 total controls).

P-values from log-binomial regression models, except for log10 viral load which is based on a logistic regression model due to case-control sampling of maternal viral load

Median (interquartile range)

Viral load below the limit of detection of 400 copies/mL was set to 200